The Glaukos iStent – the first FDA-approved trabecular micro-bypass technology that improves your eye’s natural fluid outflow to safely lower eye pressure by creating a permanent opening in the trabecular meshwork is now available from Dr. Brennan Greene at The Eye Care Institute.
Patients suffering from moderate to serious open angle glaucoma may find relief as this Micro Invasive Glaucoma Surgery (MIGS) procedure provides important new options in glaucoma therapy. That is because MIGS procedures are designed to reduce intraocular eye pressure by improving aqueous outflow through the natural physiologic pathway. In addition, MIGS procedures preserve important eye tissue and future treatment options that could help maintain long-term vision.
Brennan P. Greene, MD was a principal investigator of this surgical procedure when data was being collected for submission to the FDA to have this surgical procedure become approved for use in the United States. Dr. Greene performed the procedure at the time of cataract surgery on several of our own patients and submitted the findings to the study sponsor for inclusion in the clinical trial findings. As such, from 2005 to 2010, Dr Greene helped develop the data and create the results that Glaukos needed to submit to the federal government so that the FDA would approve this revolutionary new treatment.
A few weeks ago the treatment was approved by the FDA. Dr. Greene is already scheduling certain of his glaucoma patients to have this procedure in conjunction with their cataract surgery. If you have moderate to serious open angle glaucoma be sure to ask Dr. Greene if this treatment is right for you.
